AI assistant
NEOGENOMICS INC — Director's Dealing 2022
Mar 4, 2022
32227_dirs_2022-03-03_399b5741-9f88-4304-8245-d62e1eb7011d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-03-01
Reporting Person: Bonello William (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-01 | Common Stock | A | 40869 | — | Acquired | 102742 | Direct |
| 2022-03-01 | Common Stock | F | 397 | — | Disposed | 102345 | Direct |
| 2022-03-02 | Common Stock | F | 620 | — | Disposed | 101725 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | Stock Option (Right to Buy) | $21.41 | A | 99772 | Acquired | 2029-03-01 | Common Stock (99772.0) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.52 | 2022-04-28 | Common Stock (10727.0) | 10727 | Direct |
| Stock Option (Right to Buy) | $8.03 | 2023-02-26 | Common Stock (45370.0) | 45370 | Direct |
| Stock Option (Right to Buy) | $19.6 | 2024-03-01 | Common Stock (41167.0) | 41167 | Direct |
| Stock Option (Right to Buy) | $28.33 | 2027-03-02 | Common Stock (37514.0) | 37514 | Direct |
| Stock Option (Right to Buy) | $53.17 | 2028-03-02 | Common Stock (24619.0) | 24619 | Direct |
Footnotes
F1: On March 1, 2022, Mr. Bonello was granted 40,869 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F2: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2022 vesting of restricted stock.
F3: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock.
F4: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F5: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F6: On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F7: On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F8: On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F9: On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date.